196 related articles for article (PubMed ID: 25970779)
1. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.
Shi J; Liu W; Sui F; Lu R; He Q; Yang Q; Lv H; Shi B; Hou P
Oncotarget; 2015 Jun; 6(16):14344-59. PubMed ID: 25970779
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.
Shi J; Qu Y; Li X; Sui F; Yao D; Yang Q; Shi B; Ji M; Hou P
Cell Death Dis; 2016 Oct; 7(10):e2442. PubMed ID: 27787520
[TBL] [Abstract][Full Text] [Related]
3. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
[TBL] [Abstract][Full Text] [Related]
4. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers.
Sakakura C; Hagiwara A; Yasuoka R; Fujita Y; Nakanishi M; Masuda K; Kimura A; Nakamura Y; Inazawa J; Abe T; Yamagishi H
Int J Cancer; 2000 May; 89(3):217-23. PubMed ID: 10861496
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CCAR1, a Coactivator of β-Catenin, Suppresses the Proliferation and Migration of Gastric Cancer Cells.
Chang TS; Wei KL; Lu CK; Chen YH; Cheng YT; Tung SY; Wu CS; Chiang MK
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230774
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4.
He L; Deng H; Liu S; Chen J; Li B; Wang C; Wang X; Jiang Y; Ma N; Liu M; Xie D
Cancer Commun (Lond); 2018 Aug; 38(1):53. PubMed ID: 30103827
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
Burandt E; Jens G; Holst F; Jänicke F; Müller V; Quaas A; Choschzick M; Wilczak W; Terracciano L; Simon R; Sauter G; Lebeau A
Breast Cancer Res Treat; 2013 Feb; 137(3):745-53. PubMed ID: 23322234
[TBL] [Abstract][Full Text] [Related]
9. NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways.
Li Y; Liang J; Dang H; Zhang R; Chen P; Shao Y
Endocrine; 2022 Jan; 75(1):149-158. PubMed ID: 34251576
[TBL] [Abstract][Full Text] [Related]
10. AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1.
Tong ZT; Wei JH; Zhang JX; Liang CZ; Liao B; Lu J; Fan S; Chen ZH; Zhang F; Ma HH; Qian WC; Kong LL; Fang Y; Chen W; Xie D; Luo JH
Br J Cancer; 2013 Apr; 108(7):1470-9. PubMed ID: 23511556
[TBL] [Abstract][Full Text] [Related]
11. Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation.
You D; Zhao H; Wang Y; Jiao Y; Lu M; Yan S
Mol Cells; 2016 Sep; 39(9):663-8. PubMed ID: 27665502
[TBL] [Abstract][Full Text] [Related]
12. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
Yan J; Tsai SY; Tsai MJ
Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
[TBL] [Abstract][Full Text] [Related]
13. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
[TBL] [Abstract][Full Text] [Related]
14. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
16. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
17. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
Li Z; Yu X; Wang Y; Shen J; Wu WK; Liang J; Feng F
Oncotarget; 2015 Jul; 6(19):17559-69. PubMed ID: 25654811
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.
Yan J; Erdem H; Li R; Cai Y; Ayala G; Ittmann M; Yu-Lee LY; Tsai SY; Tsai MJ
Cancer Res; 2008 Jul; 68(13):5460-8. PubMed ID: 18593949
[TBL] [Abstract][Full Text] [Related]
19. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
20. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]